Clinical Scorecard: SEE Program Strengthens Adherence
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma |
| Key Mechanisms | Motivational interviewing, personalized multimedia education, automated medication reminders, real-time feedback |
| Target Population | Adults with glaucoma self-reporting poor adherence to ocular hypotensive medication |
| Care Setting | University of Michigan and Henry Ford Health System |
Key Highlights
- SEE program improved adherence from 64% to 78% compared to 58% in controls
- 55% of SEE participants achieved at least 80% adherence versus 24% in controls
- Significant reduction in glaucoma-related distress in SEE participants
- Intervention included in-person sessions and phone calls with a trained coach
- Study supports multifaceted, personalized adherence interventions over single-component strategies
Guideline-Based Recommendations
Diagnosis
- Assess self-reported adherence in patients with glaucoma
Management
- Implement motivational interviewing-based coaching to enhance medication adherence
Monitoring & Follow-up
- Use electronic bottle monitors to track adherence rates
Risks
- Consider emotional burden and regimen-related distress in treatment plans
Patient & Prescribing Data
Adults with glaucoma experiencing poor medication adherence
Personalized coaching and education can significantly improve adherence and reduce distress
Clinical Best Practices
- Incorporate structured coaching and motivational interviewing in patient education
- Utilize technology for real-time adherence monitoring and feedback
- Tailor educational content to individual patient needs
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
